These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 28736385

  • 1. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation).
    Patti G, Lucerna M, Pecen L, Siller-Matula JM, Cavallari I, Kirchhof P, De Caterina R.
    J Am Heart Assoc; 2017 Jul 23; 6(7):. PubMed ID: 28736385
    [Abstract] [Full Text] [Related]

  • 2. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF, Conen D, Olshansky B, Halperin JL, Hayek E, Huisman MV, Lip GYH, Lu S, Healey JS.
    Clin Cardiol; 2018 Jun 23; 41(6):744-751. PubMed ID: 29546729
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB, Schilling R, Kotecha D, Lucerna M, Huber K, De Caterina R, Kirchhof P.
    BMJ Open; 2019 Mar 30; 9(3):e022478. PubMed ID: 30928922
    [Abstract] [Full Text] [Related]

  • 4. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I, Liu Y, Alu MC, Liu M, Madhavan M, Chakravarty T, Makkar R, Thourani VH, Biviano A, Kodali S, Leon MB.
    JACC Cardiovasc Interv; 2019 Aug 26; 12(16):1580-1589. PubMed ID: 31439338
    [Abstract] [Full Text] [Related]

  • 5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L, Wong YH, Reddy VY, Boersma LVA, Bergmann MW, Doshi S, Kar S, Sievert H, Wehrenberg S, Stein K, Holmes DR.
    JACC Cardiovasc Interv; 2019 Jun 10; 12(11):1055-1063. PubMed ID: 31171282
    [Abstract] [Full Text] [Related]

  • 6. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.
    Europace; 2015 Dec 10; 17(12):1777-86. PubMed ID: 26321406
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J.
    Clin Res Cardiol; 2016 Mar 10; 105(3):225-9. PubMed ID: 26318322
    [Abstract] [Full Text] [Related]

  • 8. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G, Ducrocq G, Elbez Y, Van Belle E, Goto S, Cannon CP, Bauters C, Bhatt DL, Steg PG, REACH Investigators.
    Clin Cardiol; 2017 Oct 10; 40(10):932-939. PubMed ID: 28692742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS, Lip GY.
    Prog Cardiovasc Dis; 2015 Oct 10; 58(2):177-94. PubMed ID: 26162958
    [Abstract] [Full Text] [Related]

  • 11. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
    Olivier CB, Fan J, Askari M, Mahaffey KW, Heidenreich PA, Perino AC, Leef GC, Ho PM, Harrington RA, Turakhia MP.
    Circ Cardiovasc Interv; 2019 Aug 10; 12(8):e007604. PubMed ID: 31416357
    [Abstract] [Full Text] [Related]

  • 12. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
    Lau WCY, Douglas IJ, Wong ICK, Smeeth L, Lip GYH, Leung WK, Siu CW, Cheung BMY, Mok MTC, Chan EW.
    Heart Rhythm; 2020 Jan 10; 17(1):33-40. PubMed ID: 31377423
    [Abstract] [Full Text] [Related]

  • 13. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 10; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 14. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L.
    Stroke; 2015 Jan 10; 46(1):143-50. PubMed ID: 25424474
    [Abstract] [Full Text] [Related]

  • 15. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
    Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L, Ezekowitz MD, Ansell J, Kowey P, Singer DE, Gersh B, Mahaffey KW, Hylek E, Go AS, Chang P, Peterson ED, ORBIT-AF Investigators and Patients.
    Circulation; 2013 Aug 13; 128(7):721-8. PubMed ID: 23861512
    [Abstract] [Full Text] [Related]

  • 16. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study.
    Ahn HJ, Lee SR, Choi J, Lee KY, Kwon S, Choi EK, Oh S, Lip GYH.
    Europace; 2024 Feb 01; 26(2):. PubMed ID: 38290433
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Mishra A, Singh M, Acker WW, Kamboj S, Sporn D, Stapleton D, Kaluski E.
    J Cardiovasc Pharmacol; 2019 Aug 01; 74(2):82-90. PubMed ID: 31306367
    [Abstract] [Full Text] [Related]

  • 18. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW, Kim S, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Singer DE, Mahaffey KW, Kowey PR, Thomas L, Go AS, Lopes RD, Chang P, Peterson ED, Gersh BJ, ORBIT-AF Investigators.
    Circ Cardiovasc Qual Outcomes; 2013 Jul 01; 6(4):461-9. PubMed ID: 23759473
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, AF Ablation Frontier Registry.
    Circ J; 2019 Nov 25; 83(12):2418-2427. PubMed ID: 31619591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.